Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus. (Q38886874)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Lister strain vaccinia virus with thymidine kinase gene deletion is a tractable platform for development of a new generation of oncolytic virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

oncolytic virus

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

J Hughes

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

P Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

G Alusi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

H Shi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Y Chu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

J Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

V Bhakta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

A McCart

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

16 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

476-484

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25876464%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

China approves world's first oncolytic virus therapy for cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Oncolytic adenoviruses - selective retargeting to tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p).

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Effect of hypoxia on Ad5 infection, transgene expression and replication.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Lister vaccine strain of vaccinia virus armed with the endostatin-angiostatin fusion gene: an oncolytic virus superior to dl1520 (ONYX-015) for human head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

How vaccinia virus has evolved to subvert the host immune response.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Vaccinia virus preferentially infects and controls human and murine ovarian tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Targeting vaccinia to solid tumors with local hyperthermia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Angiogenesis in the corpus luteum.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Anti-asialo-GM1 inhibits vaccinia virus infection of murine ovaries: asialo-GM1 as an additional virus receptor?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Cancer despite immunosurveillance: immunoselection and immunosubversion

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Strategies for use of IL-10 or its antagonists in human disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Functional characterization of human IL-10.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Altered macrophage differentiation and immune dysfunction in tumor development

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Vaccinia virus immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

A new member of the interleukin 10-related cytokine family encoded by a poxvirus

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

Tumor promotion by tumor-associated macrophages

2 references

https://api.crossref.org/works/10.1038%2FGT.2015.13

21 January 2018

https://api.crossref.org/works/10.1038%2FGT.2015.13

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin-10 gene transfer to peritoneal mesothelial cells suppresses peritoneal dissemination of gastric cancer cells due to a persistently high concentration in the peritoneal cavity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus immune evasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper

1 reference

https://pubmed.ncbi.nlm.nih.gov/25876464

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38886874&oldid=2202236007"